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The extracellular matrix is composed of
hyaluronan of different molecular weights
that play different roles in cellular prolifer-
ation, migration, and differentiation.
The dysregulated accumulation of
hyaluronan alters the mechanical and
biochemical properties of the extracellu-
larmatrix and it is associatedwith several
pathological states.Hyaluronan (HA) is a critical element of the extracellular matrix (ECM). The regu-
lated synthesis and degradation of HAmodulates the ECM chemical and physical
properties that, in turn, influence cellular behavior. HA triggers signaling pathways
associated with the adhesion, proliferation, migration, and differentiation of cells,
mediated by its interaction with specific cellular receptors or by tuning the me-
chanical properties of the ECM. This review summarizes the recent advances on
strategies used to mimic the HA present in the ECM to study healthy or patholog-
ical cellular behavior. This includes the development of HA-based 2D and 3D
in vitro tissue models for the seeding and encapsulation of cells, respectively,
and HA particles as carriers for the targeted delivery of therapeutic agents.Biomaterials can be engineered using the
native hyaluronan backbone or chemi-
cally modified to target cells via specific
cellular receptors, such as CD44.
2D surfaces with controlled topography
and 3D hydrogels with tunedmechanical
properties and hyaluronan composition
can be designed to mimic the bioactivity
of this glycosaminoglycan in the ECM.
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The extracellular matrix (ECM) (see Glossary) is a rich and complex 3D environment mainly
composed of different bioactive polymers, such as proteins and glycosaminoglycans
(GAGs), as well as glycoconjugates such as glycoproteins and proteoglycans. This ECM acts
as a structural and functional support for cells in the different tissues of the body. The dynamic
interplay between cells and the biofunctional ECM components regulates the normal activities
of tissues through the activation of signaling cascades that modulate cellular behavior [1,2].
The highly dynamic character of the ECM includes the continuing production, degradation, and
remodeling of its components. The balanced composition of the ECM is critically important to
maintain the homeostasis of the extracellular environment. GAGs (including chondroitin sulfate,
heparan sulfate, and HA) are key components of the ECM, as they are responsible for most of
their physical properties and, more recently, they have been found to be key biofunctional ele-
ments responsible for modulating cellular behavior [3]. Among the GAGs that constitute the
ECM of human tissues, HA stands out for being the only nonsulfated one and the most abundant.
HA is a linear, negatively charged polysaccharide that contains a disaccharide repetitive unit
consisting of glucuronic acid (GlcA) and N-acetyl glucosamine (GlcNAc). In solution, and at phys-
iological pH, the negative charge of HA is balanced with different cations (e.g., Na+, Ca2+, K+)
conferring to this polysaccharide a high hydrophilic character that leads to a high water retention,
which, in turn, stabilizes its secondary structure. Under these circumstances, the carboxyl and
acetamido groups interact by H-bonding, forming a twofold helix, presented as a single-
stranded left-handed helix. Despite its hydrophilic nature, in aqueous solution, there are still
hydrophobic interactions and intermolecular H-bonds that are able to generate an unstable β-
sheet tertiary structure [4]. Under physiological conditions, HA assumes an expanded random
coil structure surrounded by water molecules, which occupies a very large volume.
HA has a simple and linear chemical structure, which is not to say that it lacks bioactivity. HA is
involved in various biological events, including cell proliferation [5] and differentiation [6], and it
contributes to the physiological balance of the ECMby conferring hydration, lubrification, andma-
trix homeostasis [7].Trends in Biotechnology, Month 2020, Vol. xx, No. xx https://doi.org/10.1016/j.tibtech.2020.06.003 1
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Glossary
Biofunctionality: characteristic of a
material/matrix related to its ability to
exert a biological function.
BMP-6: bonemorphogenetic protein 6,
known for their ability to induce the
growth of bone and cartilage,
upregulating osteogenic markers in
mesenchymal stem cells.
C2C12:myoblasts cell line derived from
mouse muscle tissue.
CaCO3: calcium carbonate typically
used for the preparation of nano-/
microparticles as inorganic templates.
CD44: a transmembrane cell surface
glycoprotein with a link module to
hyaluronan.
ERK1/2: extracellular signal-regulated
kinase 1 and 2, involved in the signaling
cascades that regulate the cells
adhesion, proliferation, migration, cell
survival, and differentiation.
Extracellular matrix (ECM):
tridimensional network composed of
proteins, glycoproteins,
glycosaminoglycan, proteoglycans, and
cytokines that provides structural and
biochemical support to cells.
FAK: focal adhesion kinase that
regulates the cellular movement and the
remodeling of the cytoskeleton, crucial
for the migration of cells.
Glycosaminoglycans (GAGs):
polysaccharides present in human
tissues.
HABP1: hyaluronan binding protein,
responsible for different cellular
functions.
HARE: hyaluronan receptor for
endocytosis mediates the systemic
clearance of hyaluronan.
HAS: hyaluronan synthase, a
transmembrane enzyme responsible for
production and extrusion of hyaluronan
to the extracellular space.
Homeostasis: biological, chemical,




Hyals: hyaluronidases, an intra- and
extracellular enzyme responsible for the
degradation of hyaluronan.
Layer-by-layer (LbL): an assembly
technique based on the deposition of
oppositely charged polyelectrolytes to
form a multilayered thin film.
LYVE1: lymphatic vessel endothelial
receptor for hyaluronan, a membrane
glycoprotein with an extracellular link
domain.
Trends in BiotechnologyIn contrast to the sulfated GAGs, HA cannot establish covalent links to proteins generating
proteoglycans. However, it plays a unique role in the ECM, as its noncovalent interactions with
different proteins occurs to generate a biofunctional outcome; these include the hyaladherins
CD44 or RHAMM, the specific HA cell surface receptors [8,9]. The interaction between HA
and its receptors activates pathways related to cell adhesion [e.g., focal adhesion kinase
(FAK)], proliferation, and migration [extracellular-regulated kinase (ERK1/2)] [10]. HA has been
also associated with different pathological states, such as cancer, as it is a modulator of invasive-
ness andmetastasis [10,11]. The biological relevance of HA has led to an increasing interest in the
evaluation of its bioactivities in the ECM and its ability to modulate cellular function. These
activities have prompted the development of different HA-based platforms to study in vitro the in-
terplay between HA and cells. These systems are being designed to evaluate not only the
bioactivities of HA [e.g., interaction with different proteins, such as growth factors (GFs)], but
also howHA canmodulate the ECMmechanical features through the deposition of HA of different
molecular weights (Mw).
The central role of HA in the onset and progression of different diseases has prompted interest in
its different bioactivities under pathological and healthy conditions. Here, we review the biological
importance of the chemical and physical structure of HA, covering the state of the art in the
influence of the Mw of HA on triggering different pathological states (e.g., cancer, tissue fibrosis);
the development of HA-based carriers (e.g., particles, hydrogels, etc.) for the delivery of therapeu-
tic drugs; and HA-based 3D microenvironments mimicking the ECM composition to evaluate the
impact of HA chemical composition and its mechano-transduction ability on the onset and
progression of cancer. Finally, we will cover HA-based materials design for therapeutic applica-
tions that are currently in the market.
Role of HA in the ECM
HA as a Structural Element in the ECM
HA is one of the major constituents of the ECM and is responsible for maintaining tissue homeo-
stasis, assuming a function of space filling element in connective tissues. Depending on its Mw,
this GAG plays different important physiological functions as a structural element of the ECM,
including maintaining the hydration of tissues, modulating diffusion and exchange of ions and bio-
molecules, and providing mechanical support for cells [12]. Moreover, its ability to interact with
other biomolecules (e.g., proteoglycans such as versican and aggrecan, and proteins such as
TGS-6 or fibronectin) present in the cellular milieu also modulates the physical properties of the
ECM through different structural rearrangements [13]. For example, the noncovalent interplay
between HA and the proteoglycan aggrecan is essential for the function of articular cartilage. In
addition, the chondroitin sulfate-based proteoglycan versican interacts with HA, being the
basis of the formation of the pericellular matrix [14].
The Mw of HA
The different Mw of HA present in the ECM (Box 1) is a key modulator of cellular behavior and
contributor to tissue homeostasis. HA induces numerous cellular responses, mainly due to its in-
teraction with different receptors. Themost well-known, and widely described in the literature, are
CD44 and RHAMM. However, there are other HA binding proteins, such as toll-like receptors 2
and 4 (TLR-2,4), hyaluronan receptor for endocytosis (HARE), hyaluronan-binding protein 1
(HABP1), and lymphatic vessel endothelial receptor for hyaluronan 1 (LYVE1) [15]. In addition,
the Mw of HA is associated with different biological functions: the short chains of HA are usually
associated with proinflammatory response, proangiogenic activity, and migration and prolifera-
tion of cells, whereas the longest chains are usually linked to cellular differentiation and anti-
inflammatory effects (Table 1).2 Trends in Biotechnology, Month 2020, Vol. xx, No. xx
Mechano-transduction: the capacity
of amaterial to induce cellular signaling in
response to a mechanical stimulus.
NSCLC: human non-small cell lung
cancer
PEG: polyethylene glycol, a hydrophilic
molecule with different biomedical,
chemical, and industrial applications.
PEI: polyethyleneimine, a linear or
branched aliphatic polyamine.
PLL: poly-L-lysine, a positively charged
polyelectrolyte.
RHAMM: receptor for hyaluronan-
mediated motility.
RhoA: protein involved in the regulation
of cell adhesion, morphology, polarity,
and migration through the activation of
signal transduction pathways.
ROS: reactive oxygen species,
consisting of radical and nonradical
oxygen species.
SiO2: silicon dioxide.
siRNA: small interfering RNA or
silencing RNA.
SMCs: smooth muscle cells, crucial in
the formation and function of the
cardiovascular, respiratory, and
digestive systems, among others.
TGF-β1: transforming growth factor-β1.
TGS-6: tumor necrosis factor-stimulated
gene-6.
TiO2: titanium dioxide.
TLRs: toll-like receptors, a
transmembrane protein located in the
plasma membrane (TLR 1,2,4,5, and
6) and in the membranes of endosomes
and lysosomes (TLRs 3, 7, 8, and 9), that
can detect human pathogens.
YAP: yes-associated protein, an
oncoprotein located in the cytoplasm
that is responsive to the external
mechanical stimuli.
Box 1. Synthesis, Structure, and Degradation of Hyaluronan
The linear structure of HA is generated and extruded through the plasma membrane to the pericellular and extracellular
space, in a process mediated by the transmembrane synthases HASs. At their cytoplasmic domain, HASs catalyze the
reaction between UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylglucosamine (UDP-GlcNAc) with the reducing
end of the HA chain, promoting its elongation. Depending on the type of HAS responsible for the synthesis, HA are
generated with different Mw: HAS3 produces the shortest chains, between 1 × 10
5 and 2 × 105 Da, and HAS1 and HAS2
generate the longest ones, from 2 × 105 to 2 × 106 Da (Figure I), reaching polymer lengths of approximately 25 μm [91].
Balanced deposition and degradation of HA at the ECM is vital to maintain the homeostasis of the cellular environment. In
this context, while the HASs regulate the deposition of HA, the Hyals and free radicals, such as reactive oxygen species
(ROS), are key elements that control the degradation of HA, contributing to their turnover at the ECM [92]. While Hyal1
is an intracellular enzyme, Hyal2, a glycosylphosphatidylinositol (GPI)-linked enzyme, is anchored to the cell membrane
at the pericellular space [93]. Despite their independent modes of action, Hyal1 and Hyal2 are important contributors to
the biochemical pathways that lead to the degradation of HA. Hyal2 cleaves HA at the cell surface, supported by the major
HA receptor, CD44, which holds the HA molecule in place for the enzyme to cleave it into small fragments; subsequently,
HA is endocytically transported to the lysosomes to be degraded by Hyal1 [93].
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Figure I. Hyaluronan Synthesis and Structure. (A) Hyaluronan (HA) molecules with different molecular weights (Mw)
are extruded from the cytoplasm to the extracellular matrix through the HA synthases (HAS1-3) pores, that link the
intracellular with the extracellular space. (B) Chemical structure of HA composed by N-acetylglucosamine and glucuronic
acid repeating units, linked by β1-3 and β1-4 glycosidic bonds. (C) Typical Mw synthesized by the three different HASs.
Abbreviations: GlcA, Glucuronic acid; GlcNAc, N-acetyl glucosamine.
Trends in BiotechnologyIn the last decades, HA has been increasingly linked to cancer invasiveness and progression, due
to its overproduction, dysregulated degradation into short HA chains (b100 kDa), and accumula-
tion at the ECMof tumors [16]. The overexpression of HA synthases and hyaluronidases in cancer
has been associated with the increased deposition of HA of different Mw on the ECM, altering cel-
lular behavior through the activation of different signaling pathways. In response to the HA present
on the ECM, CD44 and RHAMM can trigger biochemical cascades associated with cancer cell
motility [17], proliferation, or even apoptosis or latency [18]. Whereas CD44 presents a HA binding
domain (HABD) with three different binding modes that are considered the CD44-HA fingerprints,
RHAMM needs a host molecule such CD44, TRLs, and GFs, to maintain the RHAMM-HA inter-
action and exert its bioactivities [19]. The capacity of CD44 to bind to HA of different Mw isTrends in Biotechnology, Month 2020, Vol. xx, No. xx 3





Function Biological response Refs
Low Mw




Production of proinflammatory cytokines
Neuroinflammation [71]
– Macrophage activation Endothelialization [72]
15–50 RHAMM Activation of YAP1/TAZ protein Mesotheliomas malignancy [28]
RHAMM Activation of PI3K and MEK signaling pathways Human choriocarcinoma cell migration [73]
TLR-4 Upregulation of TGFβ-1, TNF-α, IL-6
Proinflammatory
Tissue repair [70]
30–60 CD44 Migration of BRO cells Melanoma cells invasion [74]
Medium Mw
50–500 RHAMM Upregulation of TGFβ-1 Cellular migration and proliferation [70]
60–800 – Upregulation of proresolving genes (arg1, il10, andmrc1) – [75]
High Mw
N800 – Proresolving mediators – [75]
1000–1800 CD44 Upregulation of TGFβ-1 Cellular migration and proliferation [70]
– Downregulation of TGFb1, CTGF, collagen I, and
collagen III
Endometrial fibrosis attenuation [76]
– Anti-inflammatory; antioxidant; block the ERK1/2
signaling pathway
Protective role in nasal inflammation [77]
CD44 Migration of MKN45 cells; cortactin phosphorylation Invasion of gastric cancer cells [17]
N2000 CD44 Activation of ERK1/2 and suppression of EGFR signaling
pathways
Embryonic stem cell differentiation, toward smooth
muscle cells
[78]
– Upregulation of ALP, Runx-2, and OCN Osteogenic differentiation [79]
Trends in Biotechnologyassociated with its free mobility at the membrane lipid rafts, as well as its ability to group into clus-
ters, generating a range of possible interactions that have been studied in different pathologies.
HA as a Space Filling Molecule and Mechano-Modulator/-Transductor
The chemical structure of HA, in particular the presence of -OH groups, is related to its high ca-
pacity to retain water and ability to swell, which makes it an ideal space-filling element. Under
physiological conditions, HA presents a stretched chain, rich in water molecules, that contribute
to its large volume, which increases with the increment of the HA Mw [20].
The critical role of HA on the viscoelastic and biomechanical balance of tissues is the basis of its
ability to act as a structural support for cells to proliferate andmigrate [21]. The secretion and deg-
radation of HA of different Mw and their distribution throughout the ECM significantly affects the
biomechanics of thematrix and, consequently, the biochemical sensing of cells, being associated
with different pathologies (Box 2). The mechano-transductor capacity of the high Mw HA is re-
ported to inhibit the proliferation of breast cancer cells by activating the Hippo pathway [22]. How-
ever, the ECM-rich high Mw HA in glioblastoma cancer tissues showed conflicting results: while
some reports show that the increased tissue density and stiffness is linked to cancer cell prolifer-
ation and motility [23], others studies report the less invasive character of cancer cells when in
contact with hydrogels containing HA of 500 kDa [24]. In addition, Pogoda and colleagues4 Trends in Biotechnology, Month 2020, Vol. xx, No. xx
Box 2. HA in Human Tissues and Associated Diseases
HA is found in most tissues, including the synovial fluid, the vitreous, the umbilical cord, and amniotic fluid. In the latter
ones, the Mw of the HA varies depending on the gestation stage [94]. The HA of high Mw acts as a functional regulator
of synovial joint fluid, giving the required viscosity and lubrication to act as a shock absorber for compressive forces. In fact,
osteoarthritis has been associated with the loss of HA of high Mw through its cleavage into HAs of low Mw, leading to a
decrease in the viscoelastic properties of cartilage and, in turn, a reduction of the mechanical resistance of the joints
[95]. In addition, the unbalanced entanglement between HA and other ECM components alter the organization and stiff-
ness of the tissues, which is associated with several diseases such as atherosclerosis and diabetic angiopathy, as well
as fibrosis. However, the major alterations in the HA content are in cancer-related pathologies, as high levels of HA were
associated with aggressiveness and poor prognosis of different types of cancer [96].
Trends in Biotechnologyshowed that glioblastoma cells seeded on softer HA surfaces presented nearly identical re-
sponses (i.e., cells spreading, proliferation, motility, and IL-8 secretion) to those seeded on stiffer
polyacrylamide substrates, showing that the main changes in the biomechanics might not be the
main feature that drives HA bioactivities in cancer pathological states [25].
The overproduction of Hyals in certain tumors drives the average Mw of HA to lower values,
which impacts in the density and viscosity of the ECM [10,20]. In fact, the presence of low Mw
HA is extensively linked to the biochemical stimulation of cellular motility rather than the physical
and/or mechanical stimulus. However, the regulation of Yes-associated protein (YAP) expres-
sion, a mechano-transducer protein [26], has been linked to the expression and activation of
CD44. In this context, HA of low Mw (i.e., 4 kDa) is reported to reduce the expression of YAP,
inhibiting its translocation to the nucleus (which is related to the proliferation and migration of
cells), through the upstream sensing of CD44 in hepatocellular carcinoma [27]. Additionally, the
HA receptor RHAMM regulates the expression of YAP via HA/RHAMM activation [28]. Matrix re-
modeling and stiffening also leads to the activation of YAP that, in turn, enables, for example, the
rearrangement of the actomyosin cytoskeleton in cancer-associated fibroblasts [29], or of laminin
in breast cancer stem cells [30]. While the mechanical properties of the matrix can induce specific
cellular responses, YAP can also regulate matrix stiffness under a positive feedback loop, by ac-
tivating the RhoA pathway increasing the actomyosin-based tension of the cytoskeleton [26].
Engineered HA-Based Biomaterials to Mimic the Extracellular Matrix
The biological relevance of HA, in particular its recognized ability to modulate cellular behavior, led
to the development of biomaterials incorporating HA, in an attempt to mimic its bioactivity and/or
generate responsive systems to deliver therapeutic agents (Figure 1, Key Figure). In the following
subsections we will discuss these HA-based biomaterials and their biological applications
(Table 2).
Particles
Particles ranging from the nano- to the macro-scale have been developed to selectively target the
extracellular space, to reach the surface of cells or to be internalized. The HA affinity with the
transmembrane receptor CD44, which is expressed in healthy cells and overexpressed in
cancerous cells, has been exploited in the development of nanoparticles to target the intracellular
space, in a ‘Trojan horse’ strategy. Different approaches have been described to prepare the HA
particles (Figure 2). The most reported methodology is its combinatory assembly with organic
nanoparticles, based on lipids, chitosan, or PEG [31]; or inorganic particles, such as SiO2, Au,
TiO2, and CaCO3 [32]. By manipulating these organic/inorganic cores, it is possible to control
the particle size, an important feature when internalization is targeted. Coating these particles
with HA increases surface porosity, which is also important for the encapsulation of therapeutic
agents. As an example, HA-coating of mesoporous SiO2 nanoparticles (pore size of ≈2.5 nm), en-
capsulated with a doxorubicin, has been used to target CD44-overexpressing cancer cells [33].Trends in Biotechnology, Month 2020, Vol. xx, No. xx 5
Key Figure
Major Hyaluronan (HA)-Mediated Signaling Cascades and HA-Based Biomaterials
Trends in Biotechnology
Figure 1. (I) Major HA-mediated signaling cascades. (II) HA-based biomaterials developed as targeted delivery systems and extracellular matrix (ECM) mimics. (A) HA
particles modified with a thermoresponsive ketone-functional copolymer and labeled with Cyanine 5.5-amine for cellular internalization and tracking [97]. (B–D) 2D
surfaces with tuned mechanical properties and different spacing of HA molecules to study its recognition by receptors/integrins. (B) Layer-by-layer (LbL) deposition of
different polyelectrolytes with defined chemical, mechanical, and topographical properties by changing the HA molecular weight (Mw) (film of HAMw-PLLFITC) [98].
(C) Block copolymer micelle nanolithography (BCMN) with thiol-end HA (atomic force microscopy image of a glass surface covered with gold nanodots); and
(D) microcontact printing with side-on immobilization of HA [99]. (E) 3D hydrogels for cell encapsulation, with tuned mechanical properties (varying the HA Mw, the
crosslinking degree, and/or the HA blended with other biocompatible materials) [58]. All the images were used and adapted, with permission, from [58,97–99].
Abbreviations: LYVE, Lymphatic vessel endothelial receptor for hyaluronan; RHAMM, receptor for hyaluronan-mediated motility; TLR, toll-like receptor.
Trends in BiotechnologyThe chemical composition of HA with available reactive groups (e.g., carboxylic acids) allows the
exploitation of electrostatic or covalent interactions with other materials. For instance, the nega-
tive charge of HA (-COO–) allows it to participate in electrostatic binding with the positively6 Trends in Biotechnology, Month 2020, Vol. xx, No. xx
Table 2. HA-Based Materials Used to Mimic the ECM and for Targeting of Cells
Material Fabrication method HA presentation Application Biological outcome Refs





Targets CD44 of breast cancer cells [80]

















Targets CD44 of HeLa cancer cells [33]
Au – PEGylated HA
for end-on
immobilization




















Oral insulin delivery Low cytotoxicity towards HT-29 cells
and protects insulin from degradation
[83]






Doxorubicin nanocarrier MMP-2 inhibition on HeLa cells [41]
2D
surfaces






Higher cell adhesion and spreading on
stiffer films, mediated by integrins
[43]









between the HA with
aggrecan and the LYVE-1
Both hyaladherins recognize sHA [44]























structures with native multilayers;
osteogenesis on small, nanoscale





MA-HA Photo-crosslinking Hydrogels Encapsulation of human
bmMSCs
Osteogenic differentiation [55]
DTT crosslinker Cell seeding of
MDA-MB-231Br cells on
varying hydrogels’ stiffness
Increased adhesion, proliferation, and




resembling the ECM of
liver
Stiffness of 1.2–4.6 kPa maintain
primary hepatocyte function
[56]
(continued on next page)
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Table 2. (continued)
Material Fabrication method HA presentation Application Biological outcome Refs
Thiol-modified
HA
PEGDA crosslinker Controlled release of
BMP-6
Induced osteogenic differentiation of











Study the PCa cell motility Invadopodia formation on PCa with







SKBR3 and 4T-1 breast
cancer cells in
dependence of HA’s Mw
Cells migration and invasion on HA of
35kDa with upregulated EMT markers;
and inhibited on HA of 117kDa
[60]
Ca2+ ionic crosslinking
of Alg containing HA
MSCs encapsulation Increased metabolic activity of MSCs in






Influence of HA on GBM
invasive phenotype
Higher invasive potential on HA-based









Supports HepG2 cells and their
proliferation; maintained APAP and TRO
drugs response
[66]









HA-ALD of 20 kDa lead to faster stress
relaxation of the IPN hydrogels,
promoting MSC spreading, collagen







Study the binding affinity
between HA and HB-EGF
Hydrogels containing HA-collagen and
sHA strongly increased the biofunction
of HB-EGF in inducing epithelial tip
formation
[63]
Study the binding affinity
of HA with TGF-β1












Abbreviations: APAP, Acetaminophen; DTT, dithiothreitol; HA-BLD, hyaluronan-benzaldehyde; IPN, interpenetrated network; PEGDA, polyethylene glycol diacrylate; TRO,
troglitazo.
Trends in Biotechnologycharged chitosan, used for the targeted delivery of siRNA or the drug everolimus to lung cancer
cells [34]. To promote the interaction between HA and the negative charged SiO2 or Au particles,
these cores are usually amine-functionalized (-NH2), or layer-by-layer (LbL) assembly is applied
to revert the surface charge of the core particles [35]. In the LbL strategy, poly-L-lysine (PLL) is the
most common polycation used as a support layer for the subsequent deposition of HA, leading to
its immobilization in the particles’ surface. The LbL assembly of PLL-HA is pH sensitive: it is
disrupted in the acidic tumor microenvironment, leading to the release of the loaded therapeutic
agent [36]. Drugs with low water solubility are usually difficult to deliver in the cellular milieu; how-
ever, they can be solubilized using electrostatically decorated nanostructured lipid carriers, with
HA as a targeting ligand for lung cancer cells [37]. HA can also be presented using gold nanopar-
ticles conjugated with end-thiolated HA (HS-HA) to promote its binding to the gold surface, gen-
erating a brush-like surface structure [38]. The recognition of the particles and their reversible/8 Trends in Biotechnology, Month 2020, Vol. xx, No. xx
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Figure 2. Active Targeting of Hyaluronan (HA)-Based Particles Used as Drug/Proteins Carriers. (A) HA assembly
from modified HA backbone; inorganic (e.g., SiO2, TiO2, Au, CaCO2) or organic (e.g., liposomes, lipids) particle cores coated
with HA; and thiol-end HA-coated gold nanoparticles. (B) Schematic representation of the ability of HA particles to act as an
extracellular mimic (i.e., biorecognition) and for the release of therapeutic drugs or as an imaging agent. Abbreviations: LbL,
layer-by-layer.
Trends in Biotechnologyirreversible attachment to the cell surface is mediated by HA receptors. In this context, it is pos-
sible to tune the targeting capacity of these particles by the changing theMws of the HA present in
the shell of the particles.
The development of polyelectrolyte complexes using native or modified HA has been reported as
well. The biological instability of native HA structures requires the use of toxic reagents for the
crosslinking (e.g., glutaraldehyde, hydrazides, among others) to maintain its structure and its
biostability with limited biodegradation [39]. These harsh crosslinking conditions are not suitable
for biomedical applications due to their cytotoxicity. In this sense, the modification of HA has beenTrends in Biotechnology, Month 2020, Vol. xx, No. xx 9
Trends in Biotechnologyexplored. One of the most commonly reported chemical modifications performed on HA is
the modification of its hydroxyl moieties into methacrylate groups, forming methacrylated-HA
(MA-HA) that can be crosslinked by UV light [40]. This MA-HA present increased stability in
physiological conditions and allows the loading and controlled release of proteins or drugs.
Other approaches have been proposed to alter the HA chemical structure relevant for the prep-
aration of particles (e.g., thiol-modified HA [41], among others).
2D Surfaces
The ability of HA to modulate cellular morphology, proliferation, and motility has been studied
in vitro using 2D substrates that mimic, in a very simplistic way, the characteristics of the ECM.
Controlled immobilization of the extended HA chain (of different Mw) on a surface using different
polycations can modulate the stiffness of the surface, the charge density, or the available HA epi-
topes that can be recognized by the cells [42]. The LbL assembly is used to immobilize HA and
different polyelectrolytes for the construction of multilayered films. The alternate dipping of a
glass slide on PLL and HA solutions generates a (PLL-HA)x surface with controlled stiffness
through the manipulation of the crosslinker concentration. This approach has been used to eval-
uate the impact of stiffness on the behavior of C2C12 myoblasts. Greater adhesion and cell
spreading were observed on stiffer films, processes that were mediated by integrins [43]. Tissue
polystyrene coverslips (TCPS) were also used to immobilize (PLL-HA) films and to evaluate the in-
fluence of HA Mw on gastric cancer cell invasiveness, mediated by the CD44 receptor [17]. The
alternative end-thiolated-HA with different chain lengths was also used to investigate the interac-
tions between the immobilized HA with aggrecan (a proteoglycan from the ECM) and the protein
LYVE-1 (a HA-sensitive cellular receptor) [44]. The surface topography can be used to study the
ability of HA to modulate cellular behavior. Cells are sensitive to the ECM’s mechanical and mor-
phological features, so micro- and nanopatterned surfaces can provide insights on cell matrix in-
teractions and its influence on the activation of downstream biochemical pathways. In fact, the
spatial organization of focal adhesions (FAs), integrins, transmembrane receptors, and cytoskel-
eton proteins are responsible for cellular adhesion and matrix remodeling (Figure 3). In this con-
text, their influence on cellular responses can be assessed using micro- and nanostructured
substrates. Different approaches can be used for micro- and nanofabrication [45], such as
photolithography, soft lithography and microcontact printing, electron beam lithography, and
block copolymer micelle nanolithography (BCMN). Selecting the best technique depends on
the desired microstructure, for example, pillars (e.g., nanoimprinting and etching) [46], stripes
(e.g., soft-lithographic technique) [47], micropatterned networks (e.g., microcontact printing)
[48], or controlled inorganic nanoparticle spacing (e.g., BCMN) [49]. Parallel ridge stripes that
mimic the shape of vascular endothelial cells (EC) when exposed to the shear stress from the
blood flow, generated under physiological conditions, were used to study the adhesion of
EC and smooth muscle cells (SMCs) on high Mw HA-modified stripes [50]. More recently,
-(PEI-[HA-PLL]11-HA) hexagonally arranged nanostructures with crosslinked polyelectrolyte mul-
tilayer with defined spacing (i.e., 733, 518, and 302 nm) and tuned mechanical properties were
used to differentiate human adipose-derived stem cells, showing that highly crosslinked surfaces
presenting HA-coated particles of smaller size (i.e., 302 nm) induced osteogenesis [51].
3D Models
3D models (such as hydrogels) can mimic the complexity of the extracellular microenvironment
and have been proposed to overcome the limitations of the 2D platforms. In this context, 3D
hydrogels can recapitulate fundamental parameters of the ECM, such as porosity, stiffness,
and hydration, which are able to act as mechano-transductors (Figure 3). By altering the porosity
and viscoelastic properties of the gels, it is possible to control the two-way diffusion of nutrients,
oxygen, and biochemical factors throughout the cell culture period [52].10 Trends in Biotechnology, Month 2020, Vol. xx, No. xx
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Figure 3. Schematic Representation of 2D Surfaces and 3DModels Used for Cellular Immobilization and Encapsulation. Cellular adhesion, spreading, and
migration on 2D surfaces is restricted to the xy plane, being the external stimulus (mechanical and topographical) unidirectional. 2D patterned surfaces with controlled
spacing, used for integrins and/or studies on the clustering of hyaluronan (HA) receptors. 3D models recreate the physical (e.g., porosity, topography), mechanical
(e.g., hydrogel density, hydration, stiffness), and chemical (e.g., growth factors, proteins) cues of the extracellular matrix (ECM), being closer mimics to study or
recapitulate the cell–cell and cell–matrix interactions.
Trends in BiotechnologyDifferent approaches have been used to prepare 3D HA-based hydrogels. Usually, it involves the
chemical modification of HA at the -COOHposition from the GlcA residue, one of the -OH positions
of the N-acetylglucosamine, or the -NHCOCH3 groups, using chemical strategies including
deacetylation, amidation, esterification, and oxidation through 2,2,6,6-tetramethylpiperidinyloxy
(TEMPO) modification through a Schiff-based reaction, among others [53,54]. The 3D HA-based
hydrogels require chemical or physical crosslinking to be able to maintain their structure and re-
semble the native HA network. One of the most common strategies is the use of methacrylated
HA (MA-HA), which is crosslinked by UV after the encapsulation of cells. The precise control of
the UV crosslinking, by regulating the time and/or intensity of the UV exposure, allows the prepa-
ration of hydrogels with different mechanical properties [55]. The physiologically relevant stiffness
of HA-based hydrogels, resembling the ECM of healthy liver (600–4600 Pa) were mimicked
using thiol-modifiedHA. Combining HA-based hydrogels with the ECM from the liver improved cel-
lular adhesion and proliferation when stiffer hydrogels were used [56]. Thiol-modified HA hydrogel
complexedwith heparin were used to encapsulateBMP-6 showing promising results onmyeloma
cell apoptosis and osteogenic differentiation of mesenchymal stromal cells [57]. The invasive char-
acter of the brain metastasizing variant cell line, MDA-MB-231Br, derived from the breast cancer
line MDA-MB-231, was probed on HA hydrogels with varying stiffness (0.2–4.5 kPa), showing in-
creased adhesion, proliferation, and migration on stiffer matrices [58]. Modified HA with aldehydesTrends in Biotechnology, Month 2020, Vol. xx, No. xx 11
Trends in Biotechnology(HAALD) and adipic acid dihydrazide (HAADH) were also applied on 3D hydrogels. These systems
were used to encapsulate prostate cancer cells (PCa) and crosslinked at 37°C. These systems
showed that the invasive features of PCa were mediated by the HA receptor RHAMM [59]. The
most common way to generate HA-based hydrogels is to chemically modify the HA, but this strat-
egy deviates from its native chemical presentation in the ECM. In order to avoid these deviations,
the use of native HA has been attempted in the development of 3D hydrogels by incorporating it
into the matrices of a supporting hydrogel. Alginate (Alg) is one of the most common materials to
immobilize native HA into a 3D hydrogel network, due to the easy handling and the possibility to
crosslink the Alg chains using mild conditions, such as Ca2+. The role of the different Mw of HA
on the migration of breast cancer cells (SKBR3) and phenotypic alterations was evaluated by
immobilizing HA of lower (35 kDa) and higher (117 kDa) Mw in Alg matrices. These models demon-
strated metastatic activity and epithelial–mesenchymal transition (EMT) in the presence of HA of 35
kDa [60]. The resemblance of the natural ECM using the native HA immobilized in an Alg network
was also used to probe the chondrogenic differentiation of mesenchymal stem cells [61]. Other
materials have been used to promote the ECM-like presentation of HA, such as
methacrylamide-functionalized gelatin (GelMA)-HA hydrogels to mimic the ECM of glioblastoma,
namely the presentation of the different Mw of HA [24]. The combination of collagen (Coll) and
HA, incorporating the ECM fibrillar elements from Coll, has been described. By altering the HA-
Coll crosslinking, it is possible to tune the mechanical properties of these hydrogels, which altered
the ability of mesenchymal stem cells to adhere, change their morphology, and generate FAs [62].
Sulfated-HA derivatives have been incorporated into HA-Coll hydrogels for wound repair, by
retaining and slowly releasing the heparin-binding epidermal growth factor (HB-EGF) [63], or for
TGF-β1 storage within the hydrogels for skin repair [64]. More recently, the modification of HA
has been pursued for the preparation of printable bioinks [65]. In fact, bioink comprising ECM-
occurring materials has been developed combining methacrylated Coll and thiolated-HA. These
components were incorporated in gelatin nanoparticles and proven to support the proliferation
of HepG2 cells [66]. A bioink containing a tyramine-derivative HA and aligned collagen type I fibers,
has been used for MSC differentiation towards chondrocytes [67].
HA-Related Products in the Market
The biological importance of HA has been extensively studied and its fundamental role in tissues
homeostasis has been increasingly recognized. Based on this knowledge, the pharmaceutical,
medical, cosmetic, and food industries have been exploiting the development of HA-related prod-
ucts. These include systems for ophthalmologic applications, dermatological fillers (e.g., anti-age
products), and treatments for osteoarthritis and vesicoureteral reflux (Table 3).Table 3. HA-Related Products in the Market Used for Biomedical Applications
HA applications Advantage Methodology/effect Refs
Ophthalmology High hydrophilicity;
viscoelasticity
Reduce eye dryness and irritation [84]
Reduce eye inflammation [85]
Osteoarthritis Lubricant capacity;
anti-inflammatory
High Mw HA intra-articular injections Stimulates de









HA-based barrier gel [88]
Interstitial
cystitis
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Outstanding Questions
How is the molecular weight of HA re-
lated to different pathological states?
How can 2D HA-presenting surfaces
be explored as simple platforms to
study cellular behavior?
Will 3D HA-based models overtake 2D
systems as better mimics of the ECM?
How will 3D HA-based models best be
used as platforms to mimic the cellular
microenvironment?
Trends in BiotechnologyThe most common application of HA is for dermatological applications. Some of these dermal
fillers contain the linear native HA, but these have a limited half-life after injection. In order to over-
come this drawback, it is becoming increasingly common to use crosslinked HA. One example is
anti-aging microstructured patches containing crosslinked HA as an antiwrinkle and moisturizer
product [68]. The benefits of HA to improve skin function go beyond its topical administration, in-
cluding HA-based food supplements that can reduce skin dryness over time [69].
Despite the extensive studies and reported literature on the use of HA (and its derivatives) as drug
delivery systems, these types of systems are still not widely available. The in vitro studies that re-
port the ability of HA-based carriers to deliver bioactive drugs and proteins, with prolonged sta-
bility and therapeutic efficacy, still need to follow the translational pipeline that leads to their
application in the clinical practice.
Concluding Remarks and Future Perspectives
We summarized the relevance of the HA-rich ECM on the cellular behavior and tissue homeostasis
and the different type of platforms that have been proposed to study HA-mediated cell–cell or cell–
ECM interactions. The importance of the HAMw on the biochemical and biophysical balance of the
ECM has been well established. The important biological functions of HA in combination with its
chemical versatility makes HA prone to different chemical modifications to improve its stability
under physiological conditions. Different approaches have been proposed to present HA on an
ECM-relevant manner, mimicking its structural, mechanical, and biochemical properties. Taking
advantage of the ability of exogenous HA to be recognized by a series of biological elements
(e.g., different HA-specific cell surface receptors), variousHA-basedmaterials have been proposed
as drug or protein carriers for extra- or intracellular delivery. Despite the increasing knowledge on
HA and its bioactivities, the structural and biological complexity of HA in the ECM is still not
completely understood. As an example, the deposition of different Mws of HA in the ECM and its
influence on the progression of cancers is still unclear and controversial (see Outstanding Ques-
tions). In these cases, the development of platforms that can mimic the HA present in the ECM
are important tools to better understand its biological functions. In this context, the development
of 3D HA-based models that resemble the ECM is becoming increasingly important. However,
the present state of the art is still far from accurately mimicking the way HA is structurally organized
in the ECM. For instance, the multiple interactions of HA with other ECM components, as well as
with the cells’ surface, should be considered during the development of new in vitro models. An-
other important point is to be able to recapitulate the increased complexity of the ECMas a function
of time (e.g., alterations on the presentation of HA under specific temporal scales, such as mimick-
ing cancer progression). Significant improvements in the HA-based models generated using differ-
ent processing methodologies (e.g., microfluidics through soft lithography, bioprinting, etc.) are
currently under development to generate improved ECM mimics.
Acknowledgments
The authors acknowledge the financial support from the European Commission’s H2020 programme, under grant
agreements H2020-WIDESPREAD-2014-668983-FORECAST, and H2020-MSCA-RISE-2019-872648-MEPHOS. S.A.
acknowledges the Portuguese Foundation for Science and Technology (FCT) for her PhD grant (SFRH/BD/112075/2015).
References
1. Manou, D. et al. (2019) The complex interplay between extra-
cellular matrix and cells in tissues. Methods Mol. Biol. 1952,
1–20
2. Mereiter, S. et al. (2019) Glycosylation in the era of cancer-
targeted therapy: where are we heading? Cancer Cell 36, 6–16
3. Soares da Costa, D. et al. (2017) Sulfation of glycosaminogly-
cans and its implications in human health and disorders. Annu.
Rev. Biomed. Eng. 19, 1–26
4. Fallacara, A. et al. (2018) Hyaluronic acid in the third millennium.
Polymers (Basel) 10, 701
5. Murakami, T. et al. (2019) Hyaluronic acid promotes
proliferation and migration of human meniscus cells via a
CD44-dependent mechanism. Connect. Tissue Res. 60,
117–127
6. Canibano-Hernandez, A. et al. (2019) Hyaluronic acid promotes
differentiation of mesenchymal stem cells from different sourcesTrends in Biotechnology, Month 2020, Vol. xx, No. xx 13
Trends in Biotechnologytoward pancreatic progenitors within three-dimensional alginate
matrixes. Mol. Pharm. 16, 834–845
7. Iturriaga, V. et al. (2017) Role of hyaluronic acid in the homeosta-
sis and therapeutics of temporomandibular joint osteoarthritis.
Int. J. Morphol. 35, 870–876
8. Mereiter, S. et al. (2019) O-glycan truncation enhances cancer-
related functions of CD44 in gastric cancer. FEBS Lett. 593,
1675–1689
9. Senbanjo, L.T. and Chellaiah, M.A. (2017) CD44: a multifunc-
tional cell surface adhesion receptor is a regulator of progression
and metastasis of cancer cells. Front. Cell Dev. Biol. 5, 18
10. Chanmee, T. et al. (2016) Hyaluronan: a modulator of the tumor
microenvironment. Cancer Lett. 375, 20–30
11. Wu, R.-L. et al. (2017) Hyaluronic acid in digestive cancers.
J. Cancer Res. Clin. Oncol. 143, 1–16
12. Richter, R.P. et al. (2018) Glycosaminoglycans in extracellular
matrix organisation: are concepts from soft matter physics key
to understanding the formation of perineuronal nets? Curr.
Opin. Struct. Biol. 50, 65–74
13. Herrera, J. et al. (2018) Extracellular matrix as a driver of progres-
sive fibrosis. J. Clin. Invest. 128, 45–53
14. Wight, T.N. (2017) Provisional matrix: a role for versican and
hyaluronan. Matrix Biol. 60-61, 38–56
15. Price, Z.K. et al. (2018) Differing roles of hyaluronan molecular
weight on cancer cell behavior and chemotherapy resistance.
Cancers 10, 482
16. Liu, M. et al. (2019) Dissecting the dual nature of hyaluronan in
the tumor microenvironment. Front. Immunol. 10, 947
17. Amorim, S. et al. (2018) Molecular weight of surface immobilized
hyaluronic acid influences CD44-mediated binding of gastric
cancer cells. Sci. Rep. 8, 16058
18. Kassim, Y.L. et al. (2017) Three dimensional tumor engineering
by co-culture of breast tumor and endothelial cells using a
hyaluronic acid hydrogel model. J. Clin. Exp. Oncol. 6, 5
19. Vuorio, J. et al. (2017) Atomistic fingerprint of hyaluronan-CD44
binding. PLoS Comput. Biol. 13, e1005663
20. Cowman, M.K. et al. (2015) Viscoelastic properties of hyaluronan
in physiological conditions. F1000Res. 4, 622
21. Caires, R. et al. (2015) Hyaluronan modulates TRPV1 channel
opening, reducing peripheral nociceptor activity and pain. Nat.
Commun. 6, 8095
22. Ooki, T. et al. (2019) High-molecular-weight hyaluronan is a
Hippo pathway ligand directing cell density-dependent growth
inhibition via PAR1b. Dev. Cell 49, 590–604
23. Kim, Y. and Kumar, S. (2014) CD44-mediated adhesion to
hyaluronic acid contributes to mechanosensing and invasive
motility. Mol. Cancer Res. 12, 1416–1429
24. Chen, J.W.E. et al. (2018) Influence of hyaluronic acid transitions
in tumor microenvironment on glioblastoma malignancy and in-
vasive behavior. Front. Mater. 5, 39
25. Pogoda, K. et al. (2017) Soft substrates containing hyaluronan
mimic the effects of increased stiffness on morphology, motility,
and proliferation of glioma cells. Biomacromolecules 18,
3040–3051
26. Dobrokhotov, O. et al. (2018) Mechanoregulation and pathology
of YAP/TAZ via Hippo and non-Hippo mechanisms. Clin. Transl.
Med. 7, 23
27. Fan, Z.H. et al. (2018) Standard CD44 modulates YAP1 through
a positive feedback loop in hepatocellular carcinoma. Biomed.
Pharmacother. 103, 147–156
28. Shigeeda, W. et al. (2017) Hyaluronic acid enhances cell migra-
tion and invasion via the YAP1/TAZ-RHAMM axis in malignant
pleural mesothelioma. Oncotarget 8, 93729–93740
29. Calvo, F. et al. (2013) Mechanotransduction and YAP-
dependent matrix remodelling is required for the generation
and maintenance of cancer-associated fibroblasts. Nat. Cell
Biol. 15, 637–646
30. Mercurio, A. et al. (2015) A laminin 511 matrix is regulated by
TAZ and functions as the ligand for the a6Bb1 integrin to sustain
breast cancer stem cells. FASEB J. 29, 1–6
31. Yan, X.J. et al. (2019) Hyaluronic acid/PEGylated amphiphilic
nanoparticles for pursuit of selective intracellular doxorubicin
release. J. Mater. Chem. B 7, 95–102
32. Trofimov, A.D. et al. (2018) Porous inorganic carriers based on
silica, calcium carbonate and calcium phosphate for controlled/
modulated drug delivery: fresh outlook and future perspectives.
Pharmaceutics 10, 167
33. Zhang, J. et al. (2016) Multifunctional mesoporous silica
nanoparticles modified with tumor-shedable hyaluronic acid as
carriers for doxorubicin. Colloids Surf. B Biointerfaces 144,
293–302
34. Zhang, W. et al. (2019) Antitumor effect of hyaluronic-acid-
modified chitosan nanoparticles loaded with siRNA for targeted
therapy for non-small cell lung cancer. Int. J. Nanomedicine
14, 5287–5301
35. Ferreira, H. et al. (2018) The functionalization of natural polymer-
coated gold nanoparticles to carry bFGF to promote tissue
regeneration. J. Mater. Chem. B 6, 2104–2115
36. Dreaden, E.C. et al. (2014) Bimodal tumor-targeting frommicroenvi-
ronment responsive hyaluronan layer-by-layer (LbL) nanoparticles.
ACS Nano 8, 8374–8382
37. Mahmoudi, S. et al. (2019) Targeted hyaluronic acid-based lipid
nanoparticle for apigenin delivery to induce Nrf2-dependent ap-
optosis in lung cancer cells. J. Drug Deliv. Sci. Technol. 49,
268–276
38. Karakocak, B.B. et al. (2018) Hyaluronate coating enhances the
delivery and biocompatibility of gold nanoparticles. Carbohydr.
Polym. 186, 243–251
39. Khunmanee, S. et al. (2017) Crosslinking method of hyaluronic-
based hydrogel for biomedical applications. J. Tissue Eng. 8,
2041731417726464
40. Kim, K. et al. (2019) Hyaluronic acid-coated nanomedicine for
targeted cancer therapy. Pharmaceutics 11, 301
41. Gurav, D.D. et al. (2016) pH-responsive targeted and controlled
doxorubicin delivery using hyaluronic acid nanocarriers. Colloids
Surf. B Biointerfaces 143, 352–358
42. Amorim, S. et al. (2020) Tunable layer-by-layer films containing
hyaluronic acid and their interactions with CD44. J. Mater.
Chem. B 8, 3880–3885
43. Ren, K. et al. (2010) Manipulation of the adhesive behaviour of
skeletal muscle cells on soft and stiff polyelectrolyte multilayers.
Acta Biomater. 6, 4238–4248
44. Minsky, B.B. et al. (2016) Controlled immobilization strategies to
probe short hyaluronan-protein interactions. Sci. Rep. 6, 21608
45. Ermis, M. et al. (2018) Micro and nanofabrication methods to
control cell-substrate interactions and cell behavior: a review
from the tissue engineering perspective. Bioact. Mater. 3,
355–369
46. Ghezzi, B. et al. (2019) Sub-micropillar spacing modulates the
spatial arrangement of mouse MC3T3-E1 osteoblastic cells.
Nanomaterials (Basel) 9, 1701
47. Joo, S. et al. (2015) Effects of ECM protein micropatterns on the
migration and differentiation of adult neural stem cells. Sci. Rep.
5, 13043
48. Hondrich, T.J.J. et al. (2019) Improvements of microcontact print-
ing for micropatterned cell growth by contrast enhancement.
Micromachines (Basel) 10, 659
49. Schaufler, V. et al. (2016) Selective binding and lateral clustering
of alpha5beta1 and alphavbeta3 integrins: unraveling the spatial
requirements for cell spreading and focal adhesion assembly.
Cell Adhes. Migr. 10, 505–515
50. Li, J.G. et al. (2015) Tailoring of the titanium surface by preparing
cardiovascular endothelial extracellular matrix layer on the
hyaluronic acid micro-pattern for improving biocompatibility.
Colloids Surf. B Biointerfaces 128, 201–210
51. Niepel, M.S. et al. (2019) Polyelectrolyte multilayers of poly (l-lysine)
and hyaluronic acid on nanostructured surfaces affect stem cell
response. Nanoscale 11, 2878–2891
52. Tibbitt, M.W. and Anseth, K.S. (2009) Hydrogels as extracellular
matrix mimics for 3D cell culture. Biotechnol. Bioeng. 103,
655–663
53. Zhang, Y. et al. (2020) Implantation of a functional TEMPO-
hydrogel induces recovery from rat spinal cord transection
through promoting nerve regeneration and protecting bladder
tissue. Biomater. Sci. 8, 1695–1701
54. Serban, M.A. and Skardal, A. (2019) Hyaluronan chemistries for
three-dimensionalmatrix applications.Matrix Biol.78-79, 337–345
55. Poldervaart, M.T. et al. (2017) 3D bioprinting of methacrylated
hyaluronic acid (MeHA) hydrogel with intrinsic osteogenicity.
PLoS One 12, e017762814 Trends in Biotechnology, Month 2020, Vol. xx, No. xx
Trends in Biotechnology56. Deegan, D.B. et al. (2015) Stiffness of hyaluronic acid gels con-
taining liver extracellular matrix supports human hepatocyte
function and alters cell morphology. J. Mech. Behav. Biomed.
Mater. 55, 87–103
57. Grab, A.L. et al. (2019) Hyaluronan hydrogels delivering BMP-6
for local targeting of malignant plasma cells and osteogenic dif-
ferentiation of mesenchymal stromal cells. Acta Biomater. 96,
258–270
58. Narkhede, A.A. et al. (2018) The influence of matrix stiffness on
the behavior of brain metastatic breast cancer cells in a biomi-
metic hyaluronic acid hydrogel platform. J. Biomed. Mater.
Res. A 106, 1832–1841
59. Gurski, L.A. et al. (2012) Hyaluronan (HA) interacting proteins
RHAMM and hyaluronidase impact prostate cancer cell behavior
and invadopodia formation in 3D HA-based hydrogels. PLoS
One 7, e50075
60. Zhao, Y.F. et al. (2017) Modulating three-dimensional microenvi-
ronment with hyaluronan of different molecular weights alters
breast cancer cell invasion behavior. ACS Appl. Mater. Interfaces
9, 9327–9338
61. Canibano-Hernandez, A. et al. (2017) Alginate microcapsules in-
corporating hyaluronic acid recreate closer in vivo environment
for mesenchymal stem cells. Mol. Pharm. 14, 2390–2399
62. Lou, J. et al. (2018) Stress relaxing hyaluronic acid-collagen
hydrogels promote cell spreading, fiber remodeling, and focal ad-
hesion formation in 3D cell culture. Biomaterials 154, 213–222
63. Thones, S. et al. (2019) Hyaluronan/collagen hydrogels contain-
ing sulfated hyaluronan improve wound healing by sustained re-
lease of heparin-binding EGF-like growth factor. Acta Biomater.
86, 135–147
64. Rother, S. et al. (2019) Hyaluronan/collagen hydrogel matrices con-
taining high-sulfated hyaluronan microgels for regulating
transforming growth factor-beta1. J. Mater. Sci. Mater. Med. 30, 65
65. Weis, M. et al. (2018) Evaluation of hydrogels based on oxidized
hyaluronic acid for bioprinting. Gels 4, 82
66. Clark, C.C. et al. (2019) A mechanically robust thixotropic
collagen and hyaluronic acid bioink supplemented with gelatin
nanoparticles. Bioprinting 16, e00058
67. Schwab, A. et al. (2020) Tissue mimetic hyaluronan bioink con-
taining collagen fibers with controlled orientation modulating
cell migration and alignment. Mater. Today Bio Published online
June 1, 2020. https://doi.org/10.1016/j.mtbio.2020.100058
68. Lee, Y.J. et al. (2019) Anti-aging and hydration efficacy of a
cross-linked hyaluronic acid microstructure patch. Dermatol.
Ther. 32, e12888
69. Kawada, C. et al. (2014) Ingested hyaluronan moisturizes dry
skin. Nutr. J. 13, 70
70. D'Agostino, A. et al. (2017) Is molecular size a discriminating fac-
tor in hyaluronan interaction with human cells? Carbohydr.
Polym. 157, 21–30
71. Scuruchi, M. et al. (2016) 6-Mer hyaluronan oligosaccharides
modulate neuroinflammation and alpha-synuclein expression in
neuron-like SH-SY5Y cells. J. Cell. Biochem. 117, 2835–2843
72. Kang, L. et al. (2019) Hyaluronic acid oligosaccharide-modified col-
lagen nanofibers as vascular tissue-engineered scaffold for promot-
ing endothelial cell proliferation. Carbohydr. Polym. 223, 115106
73. Mascaro, M. et al. (2017) Low molecular weight hyaluronan in-
duces migration of human choriocarcinoma JEG-3 cells medi-
ated by RHAMM as well as by PI3K and MAPK pathways.
Histochem. Cell Biol. 148, 173–187
74. Sapudom, J. et al. (2017) Molecular weight specific impact of
soluble and immobilized hyaluronan on CD44 expressing mela-
noma cells in 3D collagen matrices. Acta Biomater. 50, 259–270
75. Rayahin, J.E. et al. (2015) High and low molecular weight
hyaluronic acid differentially influence macrophage activation.
ACS Biomater. Sci. Eng. 1, 481–493
76. Zhu, Y. et al. (2016) High molecular weight hyaluronic acid in-
hibits fibrosis of endometrium. Med. Sci. Monit. 22, 3438–3445
77. Albano, G.D. et al. (2016) Effect of high, medium, and lowmolec-
ular weight hyaluronan on inflammation and oxidative stress in an
in vitro model of human nasal epithelial cells. Mediat. Inflamm.
2016, 8727289
78. Simpson, R.M. et al. (2016) Hyaluronan is crucial for stem cell
differentiation into smooth muscle lineage. Stem Cells 34,
1225–1238
79. Zhao, N. et al. (2015) Effect of molecular weight and concentra-
tion of hyaluronan on cell proliferation and osteogenic differentia-
tion in vitro. Biochem. Biophys. Res. Commun. 465, 569–574
80. Lee, S.-E. et al. (2019) Hyaluronic acid-coated solid lipid nano-
particles to overcome drug-resistance in tumor cells. J. Drug
Deliv. Sci. Technol. 50, 365–371
81. Gotov, O. et al. (2018) Hyaluronic acid-coated cisplatin conju-
gated gold nanoparticles for combined cancer treatment.
J. Ind. Eng. Chem. 65, 236–243
82. Gupta, B. et al. (2018) Hyaluronic acid-capped compact silica-
supported mesoporous titania nanoparticles for ligand-directed
delivery of doxorubicin. Acta Biomater. 80, 364–377
83. Liu, D.P. et al. (2017) Oral delivery of insulin using CaCO3-based
composite nanocarriers with hyaluronic acid coatings. Mater.
Lett. 188, 263–266
84. Rinaudo, M. (2008) Main properties and current applications of
some polysaccharides as biomaterials. Polym. Int. 57, 397–430
85. Jarvis, B. and Figgitt, D.P. (2003) Topical 3% diclofenac in 2.5%
hyaluronic acid gel: a review of its use in patients with actinic
keratoses. Am. J. Clin. Dermatol. 4, 203–213
86. Curran, M.P. (2010) Hyaluronic acid (Supartz®). Drugs Aging 27,
925–941
87. Keizers, P.H.J. et al. (2018) A high crosslinking grade of
hyaluronic acid found in a dermal filler causing adverse effects.
J. Pharm. Biomed. Anal. 159, 173–178
88. Smith, T. (2001) Gelclair: managing the symptoms of oral
mucositis. Hosp. Med. 62, 623–626
89. Kallestrup, E.B. et al. (2005) Treatment of interstitial cystitis with
Cystistat (R): a hyaluronic acid product. Scand. J. Urol. Nephrol.
39, 143–147
90. Vasvani, S. et al. (2019) Hyaluronic acid: a review on its biology,
aspects of drug delivery, route of administrations and a special
emphasis on its approved marketed products and recent clinical
studies. Int. J. Biol. Macromol. 151, 1012–1029
91. Zhu, Z. et al. (2017) Hyaluronic acid: a versatile biomaterial in tis-
sue engineering. Plast. Aesthet. Res. 4, 219–227
92. Soltes, L. et al. (2006) Degradative action of reactive oxygen
species on hyaluronan. Biomacromolecules 7, 659–668
93. Bourguignon, V. and Flamion, B. (2016) Respective roles of hy-
aluronidases 1 and 2 in endogenous hyaluronan turnover.
FASEB J. 30, 2108–2114
94. Cowman, M.K. et al. (2015) The content and size of hyaluronan
in biological fluids and tissues. Front. Immunol. 6, 261
95. Bowman, S. et al. (2018) Recent advances in hyaluronic acid
based therapy for osteoarthritis. Clin. Transl. Med. 7, 6
96. Setala, L.P. et al. (1999) Hyaluronan expression in gastric cancer
cells is associated with local and nodal spread and reduced sur-
vival rate. Br. J. Cancer 79, 1133–1138
97. Garcia, F.P. et al. (2018) A versatile method for the selective
core-crosslinking of hyaluronic acid nanogels via ketone-
hydrazide chemistry: from chemical characterization to in vivo
biodistribution. Biomater. Sci. 6, 1754–1763
98. Shen, L. et al. (2011) pH-Amplified multilayer films based on
hyaluronan: influence of HA molecular weight and concentration
on film growth and stability. Biomacromolecules 12, 1322–1331
99. Tsai, I.Y. et al. (2011) Human macrophage adhesion on polysac-
charide patterned surfaces. Soft Matter 7, 3599–3606Trends in Biotechnology, Month 2020, Vol. xx, No. xx 15
